+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Chronic Pain Therapy Solutions for Joints Market - Global Forecast 2026-2032- Product Image
Chronic Pain Therapy Solutions for Joints Market - Global Forecast 2026-2032- Product Image
Sale

Chronic Pain Therapy Solutions for Joints Market - Global Forecast 2026-2032

  • Report

  • 181 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6142643
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Chronic Pain Therapy Solutions for Joints Market is projected to reach USD 4.64 Billion in 2026. It is expected to continue growing at a CAGR of 6.10%, reaching USD 6.69 Billion by 2032.

Chronic Joint Pain Therapy Solutions: Executive Overview

Chronic joint pain is a long-duration health challenge associated with osteoarthritis, inflammatory arthritis, prior injury, age-related degeneration, and other musculoskeletal conditions. Therapy solutions span nonpharmacological care, medicines, injections, physical rehabilitation, assistive technologies, and surgical intervention. Clinical decision-making increasingly emphasizes individualized treatment, functional improvement, safety, and coordinated long-term management rather than reliance on a single modality.

Care Is Shifting Toward Multimodal, Function-Focused Management

The treatment landscape is moving toward multimodal pathways that combine exercise therapy, weight management where clinically appropriate, education, behavioral support, medicines, and procedural care. Greater attention to opioid stewardship, adverse-event reduction, shared decision-making, and earlier rehabilitation is reshaping practice. Digital monitoring, remote consultations, wearable technologies, and home-based programs are also helping extend care beyond clinical settings, although access, adherence, reimbursement, and clinical validation remain important considerations.

Artificial Intelligence Is Supporting More Personalized Joint-Pain Care

Artificial intelligence is being applied to imaging interpretation, symptom classification, clinical documentation, treatment selection, rehabilitation monitoring, and patient engagement. These tools may help identify patterns across radiographs, magnetic resonance images, electronic records, and patient-reported outcomes, potentially supporting earlier intervention and more consistent triage. Safe deployment requires representative data, transparent validation, clinician oversight, privacy safeguards, cybersecurity, and clear accountability when algorithmic recommendations influence care.

Regional Insights: Uneven Access Across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific

North America generally has broad access to specialist care, advanced imaging, rehabilitation, and procedural options, while affordability, insurance design, opioid-related policy, and rural access continue to shape treatment. Latin America is characterized by varied public and private capacity, with opportunities to expand primary-care screening, rehabilitation, and affordable medicines. Europe benefits from established clinical guidelines and public health infrastructure, but aging populations, workforce constraints, and differences in reimbursement affect availability. The Middle East is investing in modern healthcare capacity while addressing variation in specialist distribution and continuity of care. Africa faces substantial gaps in diagnostics, pain services, rehabilitation, and essential medicines, making task-shared and community-based models important. Asia-Pacific combines advanced tertiary systems with large underserved populations; urban-rural disparities, demographic aging, and differing regulatory environments influence adoption of both conventional and digital solutions.

Group Insights: Policy and Economic Blocs Shape Care Coordination

ASEAN members face diverse health-system capacities, making regional cooperation on clinical training, affordable medicines, rehabilitation, and digital-health standards especially relevant. BRICS countries combine large patient populations with major differences in financing, infrastructure, and specialist access, creating a need for scalable and locally adaptable care pathways. The European Union emphasizes evidence-based practice, cross-border health considerations, data governance, and coordinated chronic-disease management. G7 systems generally possess strong research and clinical infrastructure but must address aging, workforce pressures, affordability, and equitable access. GCC countries are expanding specialized healthcare capacity while focusing on prevention, integrated delivery, and national health transformation. NATO members reflect varied healthcare structures, but shared attention to resilience, rehabilitation, and continuity of care is relevant for both civilian and service populations.

Country Insights: Diverse Priorities in Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Russia, South Korea, Spain, the UK, and

Australia combines strong clinical guidance with significant rural and Indigenous access challenges. Brazil requires coordinated public-system pathways, affordable treatment, and broader rehabilitation capacity. Canada continues to manage geographic access, wait times, and provincial variation. China is expanding healthcare and digital capabilities while addressing regional disparities and a rapidly aging population. France and Germany have established specialist and rehabilitation systems, with ongoing attention to cost-effectiveness, workforce capacity, and care coordination. India faces major urban-rural gaps and opportunities for scalable primary-care, physiotherapy, and low-cost digital models. Italy, Spain, and the United Kingdom are balancing public-system demand, aging, waiting lists, and integrated community care. Japan’s aging population reinforces the importance of prevention, mobility preservation, and long-term functional support. Mexico needs stronger early diagnosis, pain education, rehabilitation access, and continuity between public and private providers. Russia’s care environment is shaped by geographic scale, uneven specialist availability, and the need for consistent rehabilitation and medication access. South Korea combines advanced technology adoption with increasing demand linked to aging and chronic musculoskeletal conditions.

Industry Priorities: Build Evidence-Based, Accessible, and Integrated Care Pathways

Industry leaders should prioritize therapies and services that demonstrate meaningful improvements in pain, mobility, quality of life, and safety. Partnerships across primary care, rheumatology, orthopedics, physiotherapy, pharmacy, and behavioral health can reduce fragmented treatment. Digital tools should be designed around clinical workflows and inclusive access, with robust validation and human oversight. Organizations should also strengthen real-world evidence, transparent patient information, responsible opioid stewardship, equitable pricing and distribution, workforce training, and outcome measurement that reflects patient function rather than symptoms alone.

Methodology: Structured Synthesis of Clinical, Policy, and Technology Evidence

This executive summary uses a structured, qualitative synthesis of established patterns in chronic joint-pain management across therapies, care settings, regions, country systems, and technology applications. The approach considers clinical practice developments, health-system capacity, demographic pressures, access barriers, regulatory and reimbursement context, and responsible artificial-intelligence adoption. Insights are framed as directional observations rather than quantitative market claims, and conclusions should be interpreted alongside current clinical guidelines, local policies, and independently verified evidence.

Conclusion: Better Outcomes Depend on Coordinated, Patient-Centered Management

Chronic joint pain therapy is evolving toward personalized, multimodal, and function-oriented care. The most durable progress will come from combining prevention, rehabilitation, appropriate medicines and procedures, responsible digital innovation, and stronger continuity across healthcare settings. Regional and national differences require adaptable delivery models, while artificial intelligence should remain a clinically governed support tool. Leaders that focus on safety, access, measurable outcomes, and patient participation will be better positioned to address the long-term burden of joint pain.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Chronic Pain Therapy Solutions for Joints Market, by Therapy Type
7.1. Introduction
7.2. Alternative Therapy
7.2.1. Acupuncture
7.2.2. Chiropractic
7.2.3. Herbal Remedies
7.3. Device Therapy
7.3.1. Cryotherapy Devices
7.3.2. Laser Therapy Devices
7.3.3. Transcutaneous Electrical Nerve Stimulation Devices
7.3.4. Ultrasound Therapy Devices
7.3.5. Wearable Devices
7.4. Digital Therapy
7.4.1. Mobile Applications
7.4.2. Telemedicine
7.4.3. Virtual Reality Therapy
7.5. Drug Therapy
7.5.1. Corticosteroids
7.5.2. Disease Modifying Anti Rheumatic Drugs
7.5.2.1. Biologics
7.5.2.1.1. Il 6 Inhibitors
7.5.2.1.2. Jak Inhibitors
7.5.2.1.3. Tnf Inhibitors
7.5.2.2. Hydroxychloroquine
7.5.2.3. Methotrexate
7.5.2.4. Sulfasalazine
7.5.3. Nsaids
7.5.3.1. Cox 1 Inhibitors
7.5.3.2. Cox 2 Inhibitors
7.5.4. Opioids
7.6. Physical Therapy
7.6.1. Exercise Therapy
7.6.2. Hydrotherapy
7.6.3. Manual Therapy
8. Chronic Pain Therapy Solutions for Joints Market, by Administration Route
8.1. Introduction
8.2. Injectable
8.3. Intra Articular
8.4. Oral
8.5. Topical
8.6. Transdermal
9. Chronic Pain Therapy Solutions for Joints Market, by Product Type
9.1. Introduction
9.2. Over The Counter
9.3. Prescription
10. Chronic Pain Therapy Solutions for Joints Market, by Pathology
10.1. Introduction
10.2. Gout
10.3. Osteoarthritis
10.4. Rheumatoid Arthritis
11. Chronic Pain Therapy Solutions for Joints Market, by Mechanism Of Action
11.1. Introduction
11.2. Biologics
11.2.1. Il 6 Inhibitors
11.2.2. Jak Inhibitors
11.2.3. Tnf Inhibitors
11.3. Cox Inhibitors
11.3.1. Cox 1
11.3.2. Cox 2
11.4. Hyaluronic Acid Injections
11.5. Neuromodulators
11.5.1. Capsaicin
11.5.2. Lidocaine
11.6. Platelet Rich Plasma
12. Chronic Pain Therapy Solutions for Joints Market, by Technology
12.1. Introduction
12.2. Cryotherapy Devices
12.3. Drug Delivery Systems
12.4. Laser Therapy Devices
12.5. Tens Devices
12.6. Ultrasound Therapy Devices
12.7. Wearable Devices
13. Chronic Pain Therapy Solutions for Joints Market, by End User
13.1. Introduction
13.2. Clinics
13.3. Homecare Settings
13.4. Hospitals
14. Chronic Pain Therapy Solutions for Joints Market, by Distribution Channel
14.1. Introduction
14.2. Hospital Pharmacies
14.3. Online Pharmacies
14.4. Retail Pharmacies
14.5. Specialty Clinics
15. Chronic Pain Therapy Solutions for Joints Market, by Region
15.1. Introduction
15.2. Asia-Pacific
15.3. North America
15.4. Latin America
15.5. Europe
15.6. Middle East
15.7. Africa
16. Chronic Pain Therapy Solutions for Joints Market, by Group
16.1. Introduction
16.2. ASEAN
16.3. GCC
16.4. European Union
16.5. BRICS
16.6. G7
16.7. NATO
17. Chronic Pain Therapy Solutions for Joints Market, by Country
17.1. Introduction
17.2. United States
17.3. Canada
17.4. Mexico
17.5. Brazil
17.6. United Kingdom
17.7. Germany
17.8. France
17.9. Russia
17.10. Italy
17.11. Spain
17.12. China
17.13. India
17.14. Japan
17.15. Australia
17.16. South Korea
18. Competitive Landscape
18.1. Market Share Analysis, 2025
18.2. Market Concentration Analysis, 2025
18.2.1. Concentration Ratio (CR)
18.2.2. Herfindahl Hirschman Index (HHI)
18.3. Recent Developments & Impact Analysis, 2025
18.4. Product Portfolio Analysis, 2025
18.5. Benchmarking Analysis, 2025
19. Company Profiles
19.1. Abbott Laboratories
19.2. AbbVie Inc.
19.3. Amgen Inc.
19.4. B. Braun Melsungen AG
19.5. Baxter International Inc.
19.6. Biogen Inc.
19.7. Boston Scientific Corporation
19.8. Celgene Corporation
19.9. Co-Diagnostics, Inc.
19.10. Danaher Corporation
19.11. Eli Lilly and Company
19.12. Gilead Sciences, Inc.
19.13. GlaxoSmithKline plc
19.14. Hologic, Inc.
19.15. Integra LifeSciences Holdings Corporation
19.16. Johnson & Johnson Services, Inc.
19.17. Medtronic plc
19.18. Merck & Co., Inc.
19.19. Nevro Corp.
19.20. Novartis AG
19.21. Orthofix Medical Inc.
19.22. Pfizer Inc.
19.23. Sanofi S.A.
19.24. Smith & Nephew plc
19.25. Stryker Corporation
19.26. Sun Pharmaceutical Industries Ltd.
19.27. Teva Pharmaceutical Industries Ltd.
19.28. UCB S.A.
19.29. Zimmer Biomet Holdings, Inc.
19.30. Zoetis Inc.
20. Key Experts
LIST OF FIGURES
FIGURE 1. Global Chronic Pain Therapy Solutions for Joints Market, Years Considered for the Study
FIGURE 2. Global Chronic Pain Therapy Solutions for Joints Market, Research Design
FIGURE 3. Global Chronic Pain Therapy Solutions for Joints Market, Research Framework
FIGURE 4. Global Chronic Pain Therapy Solutions for Joints Market, Data Triangulation
FIGURE 5. Global Chronic Pain Therapy Solutions for Joints Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Chronic Pain Therapy Solutions for Joints Market Size, by Therapy Type, 2025 vs 2032 (%)
FIGURE 7. Global Chronic Pain Therapy Solutions for Joints Market Size, by Therapy Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Chronic Pain Therapy Solutions for Joints Market Size, by Administration Route, 2025 vs 2032 (%)
FIGURE 9. Global Chronic Pain Therapy Solutions for Joints Market Size, by Administration Route, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Chronic Pain Therapy Solutions for Joints Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 11. Global Chronic Pain Therapy Solutions for Joints Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Chronic Pain Therapy Solutions for Joints Market Size, by Pathology, 2025 vs 2032 (%)
FIGURE 13. Global Chronic Pain Therapy Solutions for Joints Market Size, by Pathology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Chronic Pain Therapy Solutions for Joints Market Size, by Mechanism Of Action, 2025 vs 2032 (%)
FIGURE 15. Global Chronic Pain Therapy Solutions for Joints Market Size, by Mechanism Of Action, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Chronic Pain Therapy Solutions for Joints Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 17. Global Chronic Pain Therapy Solutions for Joints Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Chronic Pain Therapy Solutions for Joints Market Size, by End User, 2025 vs 2032 (%)
FIGURE 19. Global Chronic Pain Therapy Solutions for Joints Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Chronic Pain Therapy Solutions for Joints Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 21. Global Chronic Pain Therapy Solutions for Joints Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Chronic Pain Therapy Solutions for Joints Market Size, by Region, 2025 vs 2032 (%)
FIGURE 23. Global Chronic Pain Therapy Solutions for Joints Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 24. Global Chronic Pain Therapy Solutions for Joints Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 25. Global Chronic Pain Therapy Solutions for Joints Market Size, by Country, 2025 vs 2032 (%)
FIGURE 26. Global Chronic Pain Therapy Solutions for Joints Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 27. Global Chronic Pain Therapy Solutions for Joints Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Chronic Pain Therapy Solutions for Joints Market Segmentation & Coverage
TABLE 2. Global Chronic Pain Therapy Solutions for Joints Market Size, 2017-2032 (USD Million)
TABLE 3. Global Chronic Pain Therapy Solutions for Joints Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 4. Global Alternative Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Alternative Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Alternative Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Acupuncture Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Acupuncture Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Acupuncture Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Chiropractic Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Chiropractic Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Chiropractic Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Herbal Remedies Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Herbal Remedies Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Herbal Remedies Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Device Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Device Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Device Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Cryotherapy Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Cryotherapy Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Cryotherapy Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Laser Therapy Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Laser Therapy Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Laser Therapy Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Transcutaneous Electrical Nerve Stimulation Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Transcutaneous Electrical Nerve Stimulation Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Transcutaneous Electrical Nerve Stimulation Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Ultrasound Therapy Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Ultrasound Therapy Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Ultrasound Therapy Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Wearable Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Wearable Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Wearable Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Digital Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Digital Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Digital Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Mobile Applications Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Mobile Applications Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Mobile Applications Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Telemedicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Telemedicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Telemedicine Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Virtual Reality Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Virtual Reality Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Virtual Reality Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Drug Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Drug Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Drug Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Corticosteroids Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Corticosteroids Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Corticosteroids Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Disease Modifying Anti Rheumatic Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Disease Modifying Anti Rheumatic Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Disease Modifying Anti Rheumatic Drugs Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Biologics Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Biologics Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Biologics Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Il 6 Inhibitors Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Il 6 Inhibitors Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Il 6 Inhibitors Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Jak Inhibitors Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Jak Inhibitors Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Jak Inhibitors Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Tnf Inhibitors Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Tnf Inhibitors Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Tnf Inhibitors Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Hydroxychloroquine Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Hydroxychloroquine Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Hydroxychloroquine Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Methotrexate Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Methotrexate Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Methotrexate Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Sulfasalazine Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Sulfasalazine Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Sulfasalazine Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Nsaids Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Nsaids Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Nsaids Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Cox 1 Inhibitors Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Cox 1 Inhibitors Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Cox 1 Inhibitors Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Cox 2 Inhibitors Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Cox 2 Inhibitors Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Cox 2 Inhibitors Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Opioids Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Opioids Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Opioids Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Physical Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Physical Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Physical Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Exercise Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Exercise Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Exercise Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Hydrotherapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Hydrotherapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Hydrotherapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Manual Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Manual Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Manual Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Chronic Pain Therapy Solutions for Joints Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 101. Global Injectable Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Injectable Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Injectable Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global Intra Articular Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global Intra Articular Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global Intra Articular Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global Topical Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Topical Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Topical Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Transdermal Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Transdermal Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Transdermal Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Chronic Pain Therapy Solutions for Joints Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 117. Global Over The Counter Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Global Over The Counter Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. Global Over The Counter Market Size, by Country, 2017-2032 (USD Million)
TABLE 120. Global Prescription Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Global Prescription Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. Global Prescription Market Size, by Country, 2017-2032 (USD Million)
TABLE 123. Global Chronic Pain Therapy Solutions for Joints Market Size, by Pathology, 2017-2032 (USD Million)
TABLE 124. Global Gout Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Global Gout Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. Global Gout Market Size, by Country, 2017-2032 (USD Million)
TABLE 127. Global Osteoarthritis Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Global Osteoarthritis Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. Global Osteoarthritis Market Size, by Country, 2017-2032 (USD Million)
TABLE 130. Global Rheumatoid Arthritis Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Global Rheumatoid Arthritis Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. Global Rheumatoid Arthritis Market Size, by Country, 2017-2032 (USD Million)
TABLE 133. Global Chronic Pain Therapy Solutions for Joints Market Size, by Mechanism Of Action, 2017-2032 (USD Million)
TABLE 134. Global Biologics Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Global Biologics Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. Global Biologics Market Size, by Country, 2017-2032 (USD Million)
TABLE 137. Global Il 6 Inhibitors Market Size, by Region, 2017-2032 (USD Million)
TABLE 138. Global Il 6 Inhibitors Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. Global Il 6 Inhibitors Market Size, by Country, 2017-2032 (USD Million)
TABLE 140. Global Jak Inhibitors Market Size, by Region, 2017-2032 (USD Million)
TABLE 141. Global Jak Inhibitors Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. Global Jak Inhibitors Market Size, by Country, 2017-2032 (USD Million)
TABLE 143. Global Tnf Inhibitors Market Size, by Region, 2017-2032 (USD Million)
TABLE 144. Global Tnf Inhibitors Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. Global Tnf Inhibitors Market Size, by Country, 2017-2032 (USD Million)
TABLE 146. Global Cox Inhibitors Market Size, by Region, 2017-2032 (USD Million)
TABLE 147. Global Cox Inhibitors Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. Global Cox Inhibitors Market Size, by Country, 2017-2032 (USD Million)
TABLE 149. Global Cox 1 Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. Global Cox 1 Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. Global Cox 1 Market Size, by Country, 2017-2032 (USD Million)
TABLE 152. Global Cox 2 Market Size, by Region, 2017-2032 (USD Million)
TABLE 153. Global Cox 2 Market Size, by Group, 2017-2032 (USD Million)
TABLE 154. Global Cox 2 Market Size, by Country, 2017-2032 (USD Million)
TABLE 155. Global Hyaluronic Acid Injections Market Size, by Region, 2017-2032 (USD Million)
TABLE 156. Global Hyaluronic Acid Injections Market Size, by Group, 2017-2032 (USD Million)
TABLE 157. Global Hyaluronic Acid Injections Market Size, by Country, 2017-2032 (USD Million)
TABLE 158. Global Neuromodulators Market Size, by Region, 2017-2032 (USD Million)
TABLE 159. Global Neuromodulators Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. Global Neuromodulators Market Size, by Country, 2017-2032 (USD Million)
TABLE 161. Global Capsaicin Market Size, by Region, 2017-2032 (USD Million)
TABLE 162. Global Capsaicin Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. Global Capsaicin Market Size, by Country, 2017-2032 (USD Million)
TABLE 164. Global Lidocaine Market Size, by Region, 2017-2032 (USD Million)
TABLE 165. Global Lidocaine Market Size, by Group, 2017-2032 (USD Million)
TABLE 166. Global Lidocaine Market Size, by Country, 2017-2032 (USD Million)
TABLE 167. Global Platelet Rich Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 168. Global Platelet Rich Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 169. Global Platelet Rich Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 170. Global Chronic Pain Therapy Solutions for Joints Market Size, by Technology, 2017-2032 (USD Million)
TABLE 171. Global Cryotherapy Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 172. Global Cryotherapy Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 173. Global Cryotherapy Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 174. Global Drug Delivery Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 175. Global Drug Delivery Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 176. Global Drug Delivery Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 177. Global Laser Therapy Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 178. Global Laser Therapy Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 179. Global Laser Therapy Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 180. Global Tens Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 181. Global Tens Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 182. Global Tens Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 183. Global Ultrasound Therapy Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 184. Global Ultrasound Therapy Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 185. Global Ultrasound Therapy Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 186. Global Wearable Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 187. Global Wearable Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 188. Global Wearable Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 189. Global Chronic Pain Therapy Solutions for Joints Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 191. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 192. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 193. Global Homecare Settings Market Size, by Region, 2017-2032 (USD Million)
TABLE 194. Global Homecare Settings Market Size, by Group, 2017-2032 (USD Million)
TABLE 195. Global Homecare Settings Market Size, by Country, 2017-2032 (USD Million)
TABLE 196. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 197. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 198. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 199. Global Chronic Pain Therapy Solutions for Joints Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 200. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 201. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 202. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 203. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 204. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 205. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 206. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 207. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 208. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 209. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 210. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 211. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 212. Global Chronic Pain Therapy Solutions for Joints Market Size, by Region, 2017-2032 (USD Million)
TABLE 213. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Region, 2017-2032 (USD Million)
TABLE 214. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 215. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Alternative Therapy, 2017-2032 (USD Million)
TABLE 216. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Device Therapy, 2017-2032 (USD Million)
TABLE 217. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Digital Therapy, 2017-2032 (USD Million)
TABLE 218. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Drug Therapy, 2017-2032 (USD Million)
TABLE 219. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Disease Modifying Anti Rheumatic Drugs, 2017-2032 (USD Million)
TABLE 220. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 221. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Nsaids, 2017-2032 (USD Million)
TABLE 222. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Physical Therapy, 2017-2032 (USD Million)
TABLE 223. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 224. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 225. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Pathology, 2017-2032 (USD Million)
TABLE 226. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Mechanism Of Action, 2017-2032 (USD Million)
TABLE 227. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 228. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Cox Inhibitors, 2017-2032 (USD Million)
TABLE 229. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Neuromodulators, 2017-2032 (USD Million)
TABLE 230. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Technology, 2017-2032 (USD Million)
TABLE 231. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by End User, 2017-2032 (USD Million)
TABLE 232. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 233. North America Chronic Pain Therapy Solutions for Joints Market Size, by Region, 2017-2032 (USD Million)
TABLE 234. North America Chronic Pain Therapy Solutions for Joints Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 235. North America Chronic Pain Therapy Solutions for Joints Market Size, by Alternative Therapy, 2017-2032 (USD Million)
TABLE 236. North America Chronic Pain Therapy Solutions for Joints Market Size, by Device Therapy, 2017-2032 (USD Million)
TABLE 237. North America Chronic Pain Therapy Solutions for Joints Market Size, by Digital Therapy, 2017-2032 (USD Million)
TABLE 238. North America Chronic Pain Therapy Solutions for Joints Market Size, by Drug Therapy, 2017-2032 (USD Million)
TABLE 239. North America Chronic Pain Therapy Solutions for Joints Market Size, by Disease Modifying Anti Rheumatic Drugs, 2017-2032 (USD Million)
TABLE 240. North America Chronic Pain Therapy Solutions for Joints Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 241. North America Chronic Pain Therapy Solutions for Joints Market Size, by Nsaids, 2017-2032 (USD Million)
TABLE 242. North America Chronic Pain Therapy Solutions for Joints Market Size, by Physical Therapy, 2017-2032 (USD Million)
TABLE 243. North America Chronic Pain Therapy Solutions for Joints Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 244. North America Chronic Pain Therapy Solutions for Joints Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 245. North America Chronic Pain Therapy Solutions for Joints Market Size, by Pathology, 2017-2032 (USD Million)
TABLE 246. North America Chronic Pain Therapy Solutions for Joints Market Size, by Mechanism Of Action, 2017-2032 (USD Million)
TABLE 247. North America Chronic Pain Therapy Solutions for Joints Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 248. North America Chronic Pain Therapy Solutions for Joints Market Size, by Cox Inhibitors, 2017-2032 (USD Million)
TABLE 249. North America Chronic Pain Therapy Solutions for Joints Market Size, by Neuromodulators, 2017-2032 (USD Million)
TABLE 250. North America Chronic Pain Therapy Solutions for Joints Market Size, by Technology, 2017-2032 (USD Million)
TABLE 251. North America Chronic Pain Therapy Solutions for Joints Market Size, by End User, 2017-2032 (USD Million)
TABLE 252. North America Chronic Pain Therapy Solutions for Joints Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 253. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Region, 2017-2032 (USD Million)
TABLE 254. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 255. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Alternative Therapy, 2017-2032 (USD Million)
TABLE 256. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Device Therapy, 2017-2032 (USD Million)
TABLE 257. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Digital Therapy, 2017-2032 (USD Million)
TABLE 258. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Drug Therapy, 2017-2032 (USD Million)
TABLE 259. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Disease Modifying Anti Rheumatic Drugs, 2017-2032 (USD Million)
TABLE 260. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 261. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Nsaids, 2017-2032 (USD Million)
TABLE 262. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Physical Therapy, 2017-2032 (USD Million)
TABLE 263. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 264. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 265. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Pathology, 2017-2032 (USD Million)
TABLE 266. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Mechanism Of Action, 2017-2032 (USD Million)
TABLE 267. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 268. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Cox Inhibitors, 2017-2032 (USD Million)
TABLE 269. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Neuromodulators, 2017-2032 (USD Million)
TABLE 270. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Technology, 2017-2032 (USD Million)
TABLE 271. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by End User, 2017-2032 (USD Million)
TABLE 272. Latin America Chronic Pain Therapy Solutions for Joints Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 273. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Region, 2017-2032 (USD Million)
TABLE 274. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 275. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Alternative Therapy, 2017-2032 (USD Million)
TABLE 276. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Device Therapy, 2017-2032 (USD Million)
TABLE 277. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Digital Therapy, 2017-2032 (USD Million)
TABLE 278. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Drug Therapy, 2017-2032 (USD Million)
TABLE 279. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Disease Modifying Anti Rheumatic Drugs, 2017-2032 (USD Million)
TABLE 280. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 281. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Nsaids, 2017-2032 (USD Million)
TABLE 282. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Physical Therapy, 2017-2032 (USD Million)
TABLE 283. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 284. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 285. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Pathology, 2017-2032 (USD Million)
TABLE 286. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Mechanism Of Action, 2017-2032 (USD Million)
TABLE 287. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 288. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Cox Inhibitors, 2017-2032 (USD Million)
TABLE 289. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Neuromodulators, 2017-2032 (USD Million)
TABLE 290. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Technology, 2017-2032 (USD Million)
TABLE 291. Europe Chronic Pain Therapy Solutions for Joints Market Size, by End User, 2017-2032 (USD Million)
TABLE 292. Europe Chronic Pain Therapy Solutions for Joints Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 293. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Region, 2017-2032 (USD Million)
TABLE 294. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 295. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Alternative Therapy, 2017-2032 (USD Million)
TABLE 296. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Device Therapy, 2017-2032 (USD Million)
TABLE 297. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Digital Therapy, 2017-2032 (USD Million)
TABLE 298. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Drug Therapy, 2017-2032 (USD Million)
TABLE 299. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Disease Modifying Anti Rheumatic Drugs, 2017-2032 (USD Million)
TABLE 300. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 301. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Nsaids, 2017-2032 (USD Million)
TABLE 302. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Physical Therapy, 2017-2032 (USD Million)
TABLE 303. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 304. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 305. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Pathology, 2017-2032 (USD Million)
TABLE 306. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Mechanism Of Action, 2017-2032 (USD Million)
TABLE 307. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 308. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Cox Inhibitors, 2017-2032 (USD Million)
TABLE 309. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Neuromodulators, 2017-2032 (USD Million)
TABLE 310. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Technology, 2017-2032 (USD Million)
TABLE 311. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by End User, 2017-2032 (USD Million)
TABLE 312. Middle East Chronic Pain Therapy Solutions for Joints Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 313. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Region, 2017-2032 (USD Million)
TABLE 314. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 315. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Alternative Therapy, 2017-2032 (USD Million)
TABLE 316. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Device Therapy, 2017-2032 (USD Million)
TABLE 317. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Digital Therapy, 2017-2032 (USD Million)
TABLE 318. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Drug Therapy, 2017-2032 (USD Million)
TABLE 319. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Disease Modifying Anti Rheumatic Drugs, 2017-2032 (USD Million)
TABLE 320. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 321. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Nsaids, 2017-2032 (USD Million)
TABLE 322. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Physical Therapy, 2017-2032 (USD Million)
TABLE 323. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 324. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 325. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Pathology, 2017-2032 (USD Million)
TABLE 326. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Mechanism Of Action, 2017-2032 (USD Million)
TABLE 327. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 328. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Cox Inhibitors, 2017-2032 (USD Million)
TABLE 329. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Neuromodulators, 2017-2032 (USD Million)
TABLE 330. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Technology, 2017-2032 (USD Million)
TABLE 331. Africa Chronic Pain Therapy Solutions for Joints Market Size, by End User, 2017-2032 (USD Million)
TABLE 332. Africa Chronic Pain Therapy Solutions for Joints Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 333. Global Chronic Pain Therapy Solutions for Joints Market Size, by Group, 2017-2032 (USD Million)
TABLE 334. ASEAN Chronic Pain Therapy Solutions for Joints Market Size, by Group, 2017-2032 (USD Million)
TABLE 335. ASEAN Chronic Pain Therapy Solutions for Joints Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 336. ASEAN Chronic Pain Therapy Solutions for Joints Market Size, by Alternative Therapy, 2017-2032 (USD Million)
TABLE 337. ASEAN Chronic Pain Therapy Solutions for Joints Market Size, by Device Therapy, 2017-2032 (USD Million)
TABLE 338. ASEAN Chronic Pain Therapy Solutions for Joints Market Size, by Digital Therapy, 2017-2032 (USD Million)
TAB

Companies Mentioned

  • Abbott Laboratories
  • AbbVie Inc.
  • Amgen Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Biogen Inc.
  • Boston Scientific Corporation
  • Celgene Corporation
  • Co-Diagnostics, Inc.
  • Danaher Corporation
  • Eli Lilly and Company
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Hologic, Inc.
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • Medtronic plc
  • Merck & Co., Inc.
  • Nevro Corp.
  • Novartis AG
  • Orthofix Medical Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Smith & Nephew plc
  • Stryker Corporation
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • UCB S.A.
  • Zimmer Biomet Holdings, Inc.
  • Zoetis Inc.

Related Topics

Related Reports

Musculoskeletal Pain - Market Insight, Epidemiology, and Market Forecast - 2036 - Product Image

Musculoskeletal Pain - Market Insight, Epidemiology, and Market Forecast - 2036

  • Report
  • 200 Pages
  • Global
From
Pain Management Drugs Market Outlook, 2030 - Product Image

Pain Management Drugs Market Outlook, 2030

  • Report
  • 203 Pages
  • Global
From
Pain Management Drugs Market Overview, 2025-2030 - Product Image

Pain Management Drugs Market Overview, 2025-2030

  • Report
  • 138 Pages
  • Global
From
Pain Management Drugs Market Size, Share, Trends and Forecast by Drug Class, Indication, Distribution Channel, and Region, 2026-2034 - Product Image

Pain Management Drugs Market Size, Share, Trends and Forecast by Drug Class, Indication, Distribution Channel, and Region, 2026-2034

  • Report
  • 142 Pages
  • Global
From
Cold Pain Therapy - Global Strategic Business Report - Product Image

Cold Pain Therapy - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.